Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. [electronic resource]
Producer: 20110307Description: 247-54 p. digitalISSN:- 1942-7905
- Antidepressive Agents, Second-Generation -- economics
- Cost Savings
- Decision Trees
- Health Care Costs
- Humans
- Insurance Claim Review -- economics
- Insurance, Pharmaceutical Services -- economics
- Medicaid -- economics
- Monte Carlo Method
- Organizational Policy
- Probability
- Schizophrenia -- drug therapy
- United States
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.